Found: 12
Select item for more details and to access through your institution.
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.
- Published in:
- Scientific Reports, 2015, p. 18001, doi. 10.1038/srep18001
- By:
- Publication type:
- Article
IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.
- Published in:
- Scientific Reports, 2015, p. 11874, doi. 10.1038/srep11874
- By:
- Publication type:
- Article
IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep03456
- By:
- Publication type:
- Article
The Interleukin-17 Family of Cytokines in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 12, p. 3880, doi. 10.3390/ijms19123880
- By:
- Publication type:
- Article
Circulating Natural Killer Lymphocytes Are Potential Cytotoxic Effectors Against Autologous Malignant Cells in Sezary Syndrome Patients.
- Published in:
- Journal of Investigative Dermatology, 2005, v. 125, n. 6, p. 1273, doi. 10.1111/j.0022-202X.2005.23914.x
- By:
- Publication type:
- Article
Nouvelle thérapie antiangiogénique indépendante du VEGF qui cible le récepteur CD160.
- Published in:
- Médecine Sciences, 2012, v. 28, n. 1, p. 37, doi. 10.1051/medsci/2012281013
- By:
- Publication type:
- Article
Syndrome de Sézary.
- Published in:
- Hematologie, 2024, v. 30, n. 1, p. 61, doi. 10.1684/hma.2024.1838
- By:
- Publication type:
- Article
The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2731, doi. 10.1007/s00262-022-03199-0
- By:
- Publication type:
- Article
The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8.
- Published in:
- European Journal of Immunology, 2006, v. 36, n. 9, p. 2359, doi. 10.1002/eji.200635935
- By:
- Publication type:
- Article
Human and Mouse Mast Cells Express and Secrete the GPI-Anchored Isoform of CD160.
- Published in:
- Journal of Investigative Dermatology, 2011, v. 131, n. 4, p. 916, doi. 10.1038/jid.2010.412
- By:
- Publication type:
- Article
Identification of a Novel CD160<sup>+</sup>CD4<sup>+</sup> T-Lymphocyte Subset in the Skin: A Possible Role for CD160 in Skin Inflammation.
- Published in:
- Journal of Investigative Dermatology, 2007, v. 127, n. 5, p. 1161, doi. 10.1038/sj.jid.5700680
- By:
- Publication type:
- Article
Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01785-x
- By:
- Publication type:
- Article